133 related articles for article (PubMed ID: 2866965)
21. Plasma lipid fractions during bopindolol treatment in hypertensive patients.
van Brummelen P; Bolli P; Koolen MI; Staehelin HB; Bühler FR
J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S42-4. PubMed ID: 2439818
[TBL] [Abstract][Full Text] [Related]
22. Influence of atenolol and bopindolol on circadian heart rate.
Fitscha P; Meisner W; Tiso B
J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S51-4. PubMed ID: 2439821
[TBL] [Abstract][Full Text] [Related]
23. Plasma lipid fractions during long-term monotherapy with the ISA-containing beta-adrenoceptor blocker bopindolol in hypertensive patients.
Van Brummelen P; Bolli P; Koolen MI; Staehelin HB; Bühler FR
Br J Clin Pharmacol; 1984 Jan; 17(1):86-8. PubMed ID: 6691892
[TBL] [Abstract][Full Text] [Related]
24. Bopindolol in the treatment of moderate hypertension: a dose-response study.
Moleur P; Peyrieux JC; Luciani J; David D; Boissel JP
Fundam Clin Pharmacol; 1988; 2(5):431-40. PubMed ID: 2906897
[TBL] [Abstract][Full Text] [Related]
25. Bopindolol versus metoprolol in hypertension.
Westerman RF; Christensen C; Westheim A; Donker AJ
Eur J Clin Pharmacol; 1986; 31(3):379-80. PubMed ID: 2878814
[No Abstract] [Full Text] [Related]
26. Effects of bopindolol on left ventricular function during exercise in patients with coronary artery disease.
Righetti A; Mérier G; Viquerat C; Ratib O; Rutishauser W
J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S39-41. PubMed ID: 2439817
[TBL] [Abstract][Full Text] [Related]
27. Hypotensive effect of bopindolol in pithed rats.
Tanaka H; Takahashi S; Shigenobu K
Gen Pharmacol; 1993 Mar; 24(2):373-5. PubMed ID: 8097742
[TBL] [Abstract][Full Text] [Related]
28. [Beta-blockers in the treatment of hypertension in elderly patients].
Lefflerová K; Widimský J; Lupínek Z
Vnitr Lek; 1991 Feb; 37(2):128-34. PubMed ID: 1673577
[TBL] [Abstract][Full Text] [Related]
29. Antihypertensive activity of a new vasodilator, cadralazine, administered alone or in combination with a beta-blocker.
Buoninconti R; Motolese M
Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):613-6. PubMed ID: 2867048
[TBL] [Abstract][Full Text] [Related]
30. The clinical pharmacology of bopindolol, a new long-acting beta-adrenoceptor antagonist, in hypertension.
van den Meiracker AH; Man in 't Veld AJ; van Eck HJ; Boomsma F; Derkx FH; Mulder P; Schalekamp MA
Clin Pharmacol Ther; 1987 Oct; 42(4):411-9. PubMed ID: 2889554
[TBL] [Abstract][Full Text] [Related]
31. Bopindolol. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy.
Harron DW; Goa KL; Langtry HD
Drugs; 1991 Jan; 41(1):130-49. PubMed ID: 1706984
[TBL] [Abstract][Full Text] [Related]
32. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
Floras JS; Jones JV; Hassan MO; Sleight P
Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
[TBL] [Abstract][Full Text] [Related]
33. Treatment of hypertension with beta-blockers with and without intrinsic sympathomimetic activity.
Hansson L; Svensson A; Gudbrandsson T; Sivertsson R
J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S26-9. PubMed ID: 6188917
[TBL] [Abstract][Full Text] [Related]
34. MIS (Multicentric Isradipine Study of antihypertensive therapy).
Widimský J; Dzúrik R; Fetkovská N; Balazovjech I; Kvasnicka J; Lupínek Z; Mayer O; Pidrman V
Cor Vasa; 1992; 34(1):4-14. PubMed ID: 1363224
[TBL] [Abstract][Full Text] [Related]
35. Bopindolol, pindolol, and atenolol in patients with chronic obstructive lung disease.
Schiess W; Dorow P
J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S30-3. PubMed ID: 2439815
[TBL] [Abstract][Full Text] [Related]
36. Pharmacodynamic models of various beta blockers: an explanation for the long duration of action of bopindolol.
Grevel J
J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S16-9. PubMed ID: 2439812
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the antihypertensive effect of a beta-blocker with the aid of daily blood pressure profiles.
Abetel G; Karly M; Genoud G
J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S77-9. PubMed ID: 2439827
[TBL] [Abstract][Full Text] [Related]
38. Antihypertensive effect of isradipine on blood pressure at rest and during exercise.
Dvorák I; Blaha M; Nĕmcová H
Am J Hypertens; 1991 Feb; 4(2 Pt 2):144S-146S. PubMed ID: 1673616
[TBL] [Abstract][Full Text] [Related]
39. Long-term antihypertensive therapy with beta-blockers: submaximal exercise capacity and metabolic effects during exercise.
van Baak MA; Böhm RO; Arends BG; van Hooff ME; Rahn KH
Int J Sports Med; 1987 Oct; 8(5):342-7. PubMed ID: 2890591
[TBL] [Abstract][Full Text] [Related]
40. Withdrawal of the long-acting beta blocker bopindolol is not associated with beta-adrenoceptor supersensitivity.
Bolli P; Amann FW; Müller FB; Meyer B; Burckhardt D; Bühler FR
J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S64-9. PubMed ID: 2439824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
